Close Menu

NEW YORK (GenomeWeb) – Somalogic said today it has entered a collaboration with Janssen Research & Development to analyze clinical samples using its SomaScan proteomics platform.

Under the agreement, Somalogic will measure roughly 5,000 proteins in at least 15,000 clinical samples to discover and validate protein markers to help predict, diagnose, monitor, and treat disease including rheumatoid arthritis, inflammatory bowel disease, lupus, and cardiovascular and metabolic conditions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.